ABBV:NYSE
AbbVie Common Stock
$263.29
arrow_downward
-1.12%(-2.99) 1D
$263.29
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 29, 4:04:13 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
$265.45
High
$268.93
Low
$261.52
Mkt. cap
465.26B
Avg. vol.
4.24M
Volume
175.00
Dividend
2.63%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
74.47
52-wk high
$269.39
52-wk low
$190.75
EPS
$3.54
Beta
0.29
Shares outstanding
1.77B
No. of employees
57K
Open
$265.45
High
$268.93
Low
$261.52
Mkt. cap
465.26B
Avg. vol.
4.24M
Volume
175.00
Dividend
2.63%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
74.47
52-wk high
$269.39
52-wk low
$190.75
EPS
$3.54
Beta
0.29
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
Investing.com Nigeria
·
3 hours ago
AbbVie’s zumilokibart meets phase 2 atopic dermatitis endpoint By Investing.com
Stock Titan
·
3 hours ago
At 16 weeks, all three doses of AbbVie’s eczema treatment improved skin more than placebo.
Stock Titan
·
3 hours ago
Three late-breaking reports will be part of AbbVie's 60 research presentations on skin diseases.
Benzinga
·
10 hours ago
If You Invested $1000 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com